News on Bronchial_Hyperreactivity from BioPortfolio.com http://www.BioPortfolio.com Consolidated Bronchial_Hyperreactivity news from BioPortfolio.com Wed, 10 Feb 2010 10:56:08 GMT en Biological activity of celecoxib in the bronchial epithelium of current and former smokershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040524&HITNO=0&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040524&THISHREF=http://c.moreover.com/click/here.pl%3fz2538776835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040524&HITNO=0&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040524&THISHREF=http://c.moreover.com/click/here.pl%3fz2538776835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Allergen exposure increases Th2-cytokines and FOXP3 expression in asthmatic lungshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038756&HITNO=1&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038756&THISHREF=http://c.moreover.com/click/here.pl%3fz2537749560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038756&HITNO=1&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038756&THISHREF=http://c.moreover.com/click/here.pl%3fz2537749560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Selective IgA Deficiency in Children: Clinical Manifestations, Evaluation, and Managementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040999&HITNO=2&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040999&THISHREF=http://c.moreover.com/click/here.pl%3fz2538960975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040999&HITNO=2&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040999&THISHREF=http://c.moreover.com/click/here.pl%3fz2538960975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comConsultant Live: Emerging Combination Agent From Merck Will Garner Peak Year Sales Of More Than $250M For The Treatment Of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033728&HITNO=3&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033728&THISHREF=http://c.moreover.com/click/here.pl%3fz2535358216%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033728&HITNO=3&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033728&THISHREF=http://c.moreover.com/click/here.pl%3fz2535358216%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030856&HITNO=4&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030856&THISHREF=http://c.moreover.com/click/here.pl%3fz2533861549%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030856&HITNO=4&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030856&THISHREF=http://c.moreover.com/click/here.pl%3fz2533861549%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030637&HITNO=5&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030637&THISHREF=http://c.moreover.com/click/here.pl%3fz2533732851%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030637&HITNO=5&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030637&THISHREF=http://c.moreover.com/click/here.pl%3fz2533732851%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030535&HITNO=6&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030535&THISHREF=http://c.moreover.com/click/here.pl%3fz2533673459%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030535&HITNO=6&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030535&THISHREF=http://c.moreover.com/click/here.pl%3fz2533673459%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030509&HITNO=7&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030509&THISHREF=http://c.moreover.com/click/here.pl%3fz2533665837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030509&HITNO=7&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030509&THISHREF=http://c.moreover.com/click/here.pl%3fz2533665837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030485&HITNO=8&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030485&THISHREF=http://c.moreover.com/click/here.pl%3fz2533657316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030485&HITNO=8&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030485&THISHREF=http://c.moreover.com/click/here.pl%3fz2533657316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPhoenix Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030463&HITNO=9&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030463&THISHREF=http://c.moreover.com/click/here.pl%3fz2533639648%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030463&HITNO=9&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030463&THISHREF=http://c.moreover.com/click/here.pl%3fz2533639648%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USPhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030425&HITNO=10&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030425&THISHREF=http://c.moreover.com/click/here.pl%3fz2533615170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030425&HITNO=10&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030425&THISHREF=http://c.moreover.com/click/here.pl%3fz2533615170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030356&HITNO=11&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030356&THISHREF=http://c.moreover.com/click/here.pl%3fz2533582717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030356&HITNO=11&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030356&THISHREF=http://c.moreover.com/click/here.pl%3fz2533582717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million forhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030337&HITNO=12&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030337&THISHREF=http://c.moreover.com/click/here.pl%3fz2533572241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030337&HITNO=12&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030337&THISHREF=http://c.moreover.com/click/here.pl%3fz2533572241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030242&HITNO=13&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030242&THISHREF=http://c.moreover.com/click/here.pl%3fz2533518720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030242&HITNO=13&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030242&THISHREF=http://c.moreover.com/click/here.pl%3fz2533518720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030241&HITNO=14&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030241&THISHREF=http://c.moreover.com/click/here.pl%3fz2533518428%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030241&HITNO=14&MSIZE=68&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bronchial_Hyperreactivity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030241&THISHREF=http://c.moreover.com/click/here.pl%3fz2533518428%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: